The effects of ABCG5/G8 polymorphisms on plasma HDL cholesterol concentrations depend on smoking habit in the Boston Puerto Rican Health Study

Journal of Lipid Research

Volumn 50, Issue 3, 2009, Pages 565-573

  Junyent, Mireia ^a   Tucker, Katherine L ^a   Smith, Caren E ^a   Garcia Rios, Antonio ^a   Mattei, Josiemer ^a   Lai, Chao Qiang ^a   Parnell, Laurence D ^a   Ordovas, Jose M ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

Atherosclerosis; Interaction; Reverse cholesterol transport

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER G5; ABC TRANSPORTER G8; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; UNCLASSIFIED DRUG; ABCG5 PROTEIN, HUMAN; ABCG8 PROTEIN, HUMAN; LIPOPROTEIN;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HEALTH SURVEY; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PUERTO RICO; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING HABIT; AMINO ACID SUBSTITUTION; ATHEROSCLEROSIS; BLOOD; GENE LINKAGE DISEQUILIBRIUM; GENETICS; HISPANIC; MIDDLE AGED; RISK FACTOR; SMOKING; UNITED STATES;

AGED; AMINO ACID SUBSTITUTION; ATHEROSCLEROSIS; ATP-BINDING CASSETTE TRANSPORTERS; BOSTON; CHOLESTEROL, HDL; FEMALE; HAPLOTYPES; HISPANIC AMERICANS; HUMANS; LINKAGE DISEQUILIBRIUM; LIPOPROTEINS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SMOKING;

EID: 64349086606     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.P800041-JLR200     Document Type: Article

References (46)

1. Castelli,W. P., R. J. Garrison, P.W. Wilson, R. D. Abbott, S. Kalousdian, and W. B. Kannel. 1986. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. J. Am. Med. Assoc. 256: 2835-2838.
2. Campbell, S. C., R. J. Moffatt, and B. A. Stamford. 2008. Smoking and smoking cessation-The relationship between cardiovascular disease and lipoprotein metabolism: A review. Atherosclerosis. 201: 225-235.
3. Craig, W. Y., G. E. Palomaki, and J. E. Haddow. 1989. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ. 298: 784-788.
4. Lewis, G. F., and D. J. Rader. 2005. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ. Res. 96: 1221-1232.
5. Graf, G. A., L. Yu, W. P. Li, R. Gerard, P. L. Tuma, J. C. Cohen, and H. H. Hobbs. 2003. ABCG5 and ABCG8 are obligate heterodimers for protein trafficking and biliary cholesterol excretion. J. Biol. Chem. 278: 48275-48282.
6. Oram, J. F., and A. M. Vaughan. 2006. ATP-binding cassette cholesterol transporters and cardiovascular disease. Circ. Res. 99: 1031-1043.
7. Hubacek, J. A., K. E. Berge, J. C. Cohen, and H. H. Hobbs. 2001. Mutations in ATP-cassette binding proteins G5 (ABCG5) and G8 (ABCG8) causing sitosterolemia. Hum. Mutat. 18: 359-360.
8. Bjorkhem, I., K. Boberg, and E. Leitersdorf. 2001. Inborn errors in bile acid biosynthesis and storage of sterols other than cholesterol. In The Metabolic and Molecular Bases of Inherited Disease. Vol. 2. C. Scriver, A. Beaudet, W. Sly, and D. Valle, editors. McGraw-Hill, New York. 2961-2988.
9. Yu, L., R. E. Hammer, J. Li-Hawkins, K. Von Bergmann, D. Lutjohann, J. C. Cohen, and H. H. Hobbs. 2002. Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion. Proc. Natl. Acad. Sci. USA. 99: 16237-16242.
10. Yu, L., J. Li-Hawkins, R. E. Hammer, K. E. Berge, J. D. Horton, J. C. Cohen, and H. H. Hobbs. 2002. Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J. Clin. Invest. 110: 671-680.
11. Naik, S. U., X. Wang, J. S. Da Silva, M. Jaye, C. H. Macphee, M. P. Reilly, J. T. Billheimer, G. H. Rothblat, and D. J. Rader. 2006. Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo. Circulation. 113: 90-97.
12. Calpe-Berdiel, L., N. Rotllan, C. Fiévet, R. Roig, F. Blanco-Vaca, and J. C. Escola-Gil. 2008. Liver X receptor-mediated activation of reverse cholesterol transport from macrophages to feces in vivo requires ATP-binding cassette (ABC) G5/G8. J. Lipid Res. 49: 1904-1911.
13. Hubácek, J. A., K. E. Berge, J. Stefková, J. Pitha, Z. Skodová, V. Lánská, and R. Poledne. 2004. Polymorphisms in ABCG5 and ABCG8 transporters and plasma cholesterol levels. Physiol. Res. 53: 395-401.
14. Plat, J., M. C. Bragt, and R. P. Mensink. 2005. Common sequence variations in ABCG8 are related to plant sterol metabolism in healthy volunteers. J. Lipid Res. 46: 68-75.
15. Miwa, K., A. Inazu, J. Kobayashi, T. Higashikata, A. Nohara, M. Kawashiri, S. Katsuda, M. Takata, J. Koizumi, and H. Mabuchi. 2005. ATP-binding cassette transporter G8 M429V polymorphism as a novel genetic marker of higher cholesterol absorption in hypercholesterolaemic Japanese subjects. Clin. Sci. 109: 183-188.
16. Acalovschi, M., A. Ciocan, O. Mostean, S. Tirziu, E. Chiorean, H. Keppeler, R. Schirin-Sokhan, and F. Lammert. 2006. Are plasma lipid levels related to ABCG5/ABCG8 polymorphisms? A preliminary study in siblings with gallstones. Eur. J. Intern. Med. 17: 490-494.
17. Gylling, H., M. Hallikainen, J. Pihlajamäki, J. Agren, M. Laakso, R. A. Rajaratnam, R. Rauramaa, and T. A. Miettinen. 2004. Polymorphisms in the ABCG5 and ABCG8 genes associate with cholesterol absorption and insulin sensitivity. J. Lipid Res. 45: 1660-1665.
18. Wang, Y., Z. Y. Jiang, J. Fei, L. Xin, Q. Cai, Z. H. Jiang, Z. G. Zhu, T. Q. Han, and S. D. Zhang. 2007. ATP binding cassette G8 T400K polymorphism may affect the risk of gallstone disease among Chinese males. Clin. Chim. Acta. 384: 80-85.
19. Santosa, S., I. Demonty, A. H. Lichtenstein, J. M. Ordovas, and P. J. Jones. 207. Single nucleotide polymorphisms in ABCG5 and ABCG8 are associated with changes in cholesterol metabolism during weight loss. J. Lipid Res. 48: 2607-2613.
20. Weggemans, R. M., P. L. Zock, E. S. Tai, J. M. Ordovas, H. O. Molhuizen, and M. B. Katan. 2002. ATP binding cassette G5 C1950G polymorphism may affect blood cholesterol concentrations in humans. Clin. Genet. 62: 226-229.
21. Lai, C. Q., K. L. Tucker, L. D. Parnell, X. Adiconis, B. García-Bailo, J. Griffith, M. Meydani, and J. M. Ordovás. 2008. PPARGC1A variation associated with DNA damage, diabetes, and cardiovascular diseases: the Boston Puerto Rican Health Study. Diabetes. 57: 809-816.
22. Lee, I. M., and R. S. Paffenbarger, Jr. 1998. Physical activity and stroke incidence: the Harvard Alumni Health Study. Stroke. 29: 2049-2054.
23. Marinescu, V. D., I. S. Kohane, and A. Riva. 2005. MAPPER: a search engine for the computational identification of putative transcription factor binding sites in multiple genomes. BMC Bioinformatics. 6: 79.
24. Livak, K. J. 1999. Allelic discrimination using fluorogenic probes and the 5' nuclease assay. Genet. Anal. 14: 143-149.
25. Excoffier, L., and M. Slatkin. 1995. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol. Biol. Evol. 12: 921-927.
26. HelixTree Manual. Ver. 5.3.0. Accessed January 8, 2009, at http:// goldenhelix.com/HelixTreeManual/ compositehaplotypemethodchm.html#x133-75400023.7.
27. Falush, D., M. Stephens, and J. K. Pritchard. 2003. Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics. 164: 1567-1587.
28. Tsai, H. J., S. Choudhry, M. Naqvi, W. Rodriguez-Cintron, E. G. Burchard, and E. Ziv. 2005. Comparison of three methods to estimate genetic ancestry and control for stratification in genetic association studies among admixed populations. Hum. Genet. 118: 424-433.
29. Choudhry, S., M. Taub, R. Mei, J. Rodriguez-Santana, W. Rodriguez-Cintron, M. D. Shriver, E. Ziv, N. J. Risch, and E. G. Burchard. 2008. Genome-wide screen for asthma in Puerto Ricans: evidence for association with 5q23 region. Hum. Genet. 123: 455-468.
30. Wang, J., C. Einarsson, C. Murphy, P. Parini, I. Björkhem, M. Gåfvels, and G. Eggertsen. 2006. Studies on LXR- and FXR-mediated effects on cholesterol homeostasis in normal and cholic acid-depleted mice. J. Lipid Res. 47: 421-430.
31. Repa, J. J., K. E. Berge, C. Pomajzl, J. A. Richardson, H. Hobbs, and D. J. Mangelsdorf. 2002. Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta. J. Biol. Chem. 277: 18793-18800.
32. Yu, L., J. York, K. von Bergmann, D. Lutjohann, J. C. Cohen, and H. H. Hobbs. 2003. Stimulation of cholesterol excretion by the liver X receptor agonist requires ATP-binding cassette transporters G5 and G8. J. Biol. Chem. 278: 15565-15570.
33. Plösch, T., T. Kok, V. W. Bloks, M. J. Smit, R. Havinga, G. Chimini, A. K. Groen, and F. Kuipers. 2002. Increased hepatobiliary and fecal cholesterol excretion upon activation of the liver X receptor is independent of ABCA1. J. Biol. Chem. 277: 33870-33877.
34. Beyer, T. P., R. J. Schmidt, P. Foxworthy, Y. Zhang, J. Dai, W. R. Bensch, R. F. Kauffman, H. Gao, T. P. Ryan, X. C. Jiang, et al. 2004. Coadministration of a liver X receptor agonist and a peroxisome proliferator activator receptor-alpha agonist in mice: effects of nuclear receptor interplay on high-density lipoprotein and triglyceride metabolism in vivo. J. Pharmacol. Exp. Ther. 309: 861-868.
35. Grefhorst, A., B. M. Elzinga, P. J. Voshol, T. Plösch, T. Kok, V. W. Bloks, F. H. van der Sluijs, L. M. Havekes, J. A. Romijn, H. J. Verkade, et al. 2002. Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles. J. Biol. Chem. 277: 34182-34190.
36. Joseph, S. B., E. McKilligin, L. Pei, M. A. Watson, A. R. Collins, B. A. Laffitte, M. Chen, G. Noh, J. Goodman, G. N. Hagger, et al. 2002. Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc. Natl. Acad. Sci. USA. 99: 7604-7609.
37. Tontonoz, P., and D. J. Mangelsdorf. 2003. Liver X receptor signaling pathways in cardiovascular disease. Mol. Endocrinol. 17: 985-993.
38. McCall, M. R., J. J. van den Berg, F. A. Kuypers, D. L. Tribble, R. M. Krauss, L. J. Knoff, and T. M. Forte. 1994. Modification of LCAT activity and HDL structure. New links between cigarette smoke and coronary heart disease risk. Arterioscler. Thromb. 14: 248-253.
39. Haffner, S. M., D. Applebaum-Bowden, P. W. Wahl, J. J. Hoover, G. R. Warnick, J. J. Albers, and W. R. Hazzard. 1985. Epidemiological correlates of high density lipoprotein subfractions, apolipoproteins A-I, A-II, and D, and lecithin cholesterol acyltransferase. Effects of smoking, alcohol, and adiposity. Arteriosclerosis. 5: 169-177.
40. Freeman, D. J., M. J. Caslake, B. A. Griffin, J. Hinnie, C. E. Tan, T. D. Watson, C. J. Packard, and J. Shepherd. 1998. The effect of smoking on post-heparin lipoprotein and hepatic lipase, cholesteryl ester transfer protein and lecithin:cholesterol acyl transferase activities in human plasma. Eur. J. Clin. Invest. 28: 584-591.
41. Freeman, D. J., B. A. Griffin, E. Murray, G. M. Lindsay, D. Gaffney, C. J. Packard, and J. Shepherd. 1993. Smoking and plasma lipoproteins in man: effects on low density lipoprotein cholesterol levels and high density lipoprotein subfraction distribution. Eur. J. Clin. Invest. 23: 630-640.
42. Zaratin, A. C., E. C. Quintão, A. C. Sposito, V. S. Nunes, A. M. Lottenberg, R. E. Morton, and E. C. de Faria. 2004. Smoking prevents the intravascular remodeling of high-density lipoprotein particles: implications for reverse cholesterol transport. Metabolism. 53: 858-862.
43. Basso, F., L. A. Freeman, C. Ko, C. Joyce, M. J. Amar, R. D. Shamburek, T. Tansey, F. Thomas, J. Wu, B. Paigen, et al. 2007. Hepatic ABCG5/G8 overexpression reduces apoB-lipoproteins and atherosclerosis when cholesterol absorption is inhibited. J. Lipid Res. 48: 114-126.
44. -/- mice. J. Lipid Res. 45: 1429-1436.
45. Zhang, B., J. Menzin, M. Friedman, J. R. Korn, and R. T. Burge. 2008. Predicted coronary risk for adults with coronary heart disease and low HDL-C: an analysis from the US National Health and Nutrition Examination Survey. Curr. Med. Res. Opin. 24: 2711-2777.
46. Berge, K. E., K. von Bergmann, D. Lutjohann, R. Guerra, S. M. Grundy, H. H. Hobbs, and J. C. Cohen. 2002. Heritability of plasma noncholesterol sterols and relationship to DNA sequence polymorphism in ABCG5 and ABCG8. J. Lipid Res. 43: 486-494.